Clinical Trials Browser

Not yet recruiting × Leukapheresis × 90 days × Clear all

NCT07583303 2026-05-13

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute